Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014950
Filing Date
2024-11-08
Accepted
2024-11-08 07:18:33
Documents
95
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20240930x10q.htm   iXBRL 10-Q 2040551
2 EX-10.3 ymab-20240930xex10d3.htm EX-10.3 788680
3 EX-10.4 ymab-20240930xex10d4.htm EX-10.4 49300
4 EX-31.1 ymab-20240930xex31d1.htm EX-31.1 15598
5 EX-31.2 ymab-20240930xex31d2.htm EX-31.2 15591
6 EX-32.1 ymab-20240930xex32d1.htm EX-32.1 7844
7 EX-32.2 ymab-20240930xex32d2.htm EX-32.2 7856
8 GRAPHIC ymab-20240930xex10d3001.jpg GRAPHIC 51467
9 GRAPHIC ymab-20240930xex10d3002.jpg GRAPHIC 269700
10 GRAPHIC ymab-20240930xex10d3003.jpg GRAPHIC 208627
11 GRAPHIC ymab-20240930xex10d3004.jpg GRAPHIC 179713
12 GRAPHIC ymab-20240930xex10d3005.jpg GRAPHIC 77596
13 GRAPHIC ymab-20240930xex10d4001.jpg GRAPHIC 76836
  Complete submission text file 0001558370-24-014950.txt   11293760

Data Files

Seq Description Document Type Size
14 EX-101.SCH ymab-20240930.xsd EX-101.SCH 63915
15 EX-101.CAL ymab-20240930_cal.xml EX-101.CAL 46351
16 EX-101.DEF ymab-20240930_def.xml EX-101.DEF 281254
17 EX-101.LAB ymab-20240930_lab.xml EX-101.LAB 517115
18 EX-101.PRE ymab-20240930_pre.xml EX-101.PRE 445729
98 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20240930x10q_htm.xml XML 1759798
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 241437996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)